Online citations, reference lists, and bibliographies.
← Back to Search

Chitosan-based Hydrogels For Nasal Drug Delivery: From Inserts To Nanoparticles

B. Luppi, F. Bigucci, T. Cerchiara, V. Zecchi
Published 2010 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Importance of the field: Chitosan represents a multifunctional polymer, featuring both mucoadhesive and permeation-enhancing properties and therefore is a widely studied excipient for mucosal drug delivery. As regards nasal administration, chitosans have been used for the preparation of gels, solid inserts, powders and nanoparticles in which a three-dimensional network can be recognized. Areas covered in this review: This review provides a discussion of the different nasal dosage forms based on chitosan hydrogels. In the first section intranasal delivery is discuss as a useful tool for non-invasive administration of drugs intended for local or systemic treatments. Then chitosan-based hydrogels are described with a focus on their mucoadhesive and permeation-enhancing ability as well as their capacity of controlled drug release. Finally, a detailed discussion regarding several examples of the different nasal dosage forms is reported, including considerations on in vitro, ex vivo and in vivo studies. What the reader will gain: Summary and discussion of recent data on the different pharmaceutical forms based on chitosan hydrogels could be of interest to researchers dealing with nasal drug delivery. Take home message: The aim of this review is to stimulate further investigations in order to achieve the collection of harmonized data and concrete clinical perspectives.
This paper references
10.1016/J.JCIS.2004.08.186
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior.
T. López-León (2005)
10.3109/03639040903382673
In situ gelling nasal inserts for influenza vaccine delivery
Ulrike Bertram (2010)
10.1016/S0378-5173(03)00087-5
Bioadhesive microspheres as a controlled drug delivery system.
Jaspreet K. Vasir (2003)
10.1021/bm9001377
Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.
F. M. Goycoolea (2009)
10.1097/01.mlg.0000221954.05467.54
Bacterial Biofilms on the Sinus Mucosa of Human Subjects With Chronic Rhinosinusitis
A. R. Sanderson (2006)
10.1067/mhn.2002.129738
Use of Nebulized Antibiotics for Acute Infections in Chronic Sinusitis
W. Vaughan (2002)
A thermosensitive hydrogel based on quaternized CH and poly(ethylene glycol) for nasal drug delivery system. Biomaterials
J Wu (2007)
10.1016/j.otohns.2004.11.011
Chronic rhinosinusitis and biofilms
H. Ramadan (2005)
10.1016/J.BIOMATERIALS.2006.12.024
A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
J. Wu (2007)
10.1016/S0928-0987(98)00016-5
Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
A. Kotzé (1999)
CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY
W. Tiyaboonchai (2003)
10.1016/S0169-409X(97)00058-6
Anatomy, physiology and function of the nasal cavities in health and disease.
Dahl (1998)
10.1016/j.ejps.2009.07.003
Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Amjad Alhalaweh (2009)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
Pharmacokinetic attributes of intranasal delivery: case studies and new opportunities
HR Costantino (2005)
10.1023/A:1016418523014
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
10.1016/S0378-5173(99)00442-1
Determination of baseline human nasal pH and the effect of intranasally administered buffers.
N. Washington (2000)
10.1016/S0939-6411(03)00161-9
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.
J. Berger (2004)
10.1016/J.EJPB.2007.05.020
Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
Sabine Kempe (2008)
10.1016/j.addr.2009.07.019
Chitosan-based hydrogels for controlled, localized drug delivery.
N. Bhattarai (2010)
10.1016/j.biotechadv.2009.06.007
Application of chitosan microspheres for nasal delivery of vaccines.
M. L. Kang (2009)
10.1080/03639040802395185
The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration.
Y. Sun (2009)
Intranasal drug delivery for systemic medications.
Y. Chien (1987)
10.1016/S0939-6411(03)00160-7
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.
J. Berger (2004)
10.1002/JPS.20520
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.
S. Mao (2006)
10.1021/BM010151+
Viscosity of semiflexible chitosan solutions: influence of concentration, temperature, and role of intermolecular interactions.
J. Desbrières (2002)
Uptake and transport of PEGgrafttrimethylchitosan copolymernanocomplexes by epithelial cells
S Mao (2005)
10.18433/J3NC79
Intranasal drug delivery: how, why and what for?
A. Pires (2009)
10.1163/156856201750195289
A review of factors affecting the performances of latex agglutination tests
J. L. Ortega-Vinuesa (2001)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
10.3109/03639048809151972
Pharmaceutical and Medical Aspects of Bioadhesive Systems for Drug Administration
D. Duchěne (1988)
10.4103/0250-474X.36933
Mucoadhesive chitosan microspheres for non-invasive and improved nasal delivery of insulin
S. Jain (2007)
10.1016/S0378-5173(01)00873-0
In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.
S. T. Lim (2002)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1023/B:PHAR.0000026823.82950.ff
Nasal route and drug delivery systems
S. Türker (2004)
10.1016/S0378-5173(98)00027-1
In vitro evaluation of the mucoadhesive properties of chitosan microspheres
P. He (1998)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
10.1023/A:1016444808000
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
10.1211/0022357055623
Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in‐vitro/ex‐vivo studies
E. Gavini (2005)
10.1016/J.EJPS.2005.08.005
In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form.
Ulrike Bertram (2006)
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
10.1002/JPS.20718
Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?
L. Illum (2007)
10.1016/j.ejpb.2008.07.005
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Xiaomei Wang (2008)
10.1007/s11095-005-8175-y
Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells
S. Mao (2005)
10.1016/J.PROGPOLYMSCI.2009.08.001
Biopolymer-based microgels/nanogels for drug delivery applications
J. Oh (2009)
10.1080/10717540500309040
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
J. Varshosaz (2006)
10.1211/jpp.59.6.0002
The use of simple dynamic mucosal models and confocal microscopy for the evaluation of lyophilised nasal formulations
F. Mcinnes (2007)
10.1016/J.EJPB.2007.05.002
Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
E. Gavini (2008)
10.2500/aap.2009.30.3263
Intranasal antihistamines for allergic rhinitis: mechanism of action.
P. Lieberman (2009)
10.1016/S0168-3659(02)00363-2
Nasal drug delivery--possibilities, problems and solutions.
L. Illum (2003)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
10.1002/jps.21335
Brain uptake of an anti-ischemic agent by nasal administration of microparticles.
A. Dalpiaz (2008)
10.1023/B:PHAM.0000022414.17183.58
Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery
Takahiro Nagamoto (2004)
10.1021/CR030441B
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
10.1016/S0168-3659(99)00285-0
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
S. T. Lim (2000)
10.1016/0378-5173(94)90344-1
Preparation and evaluation of cross-linked chitosan microspheres containing furosemide
J. Akbuǧa (1994)
Preparations, characterizations and applications of chitosan-based nanoparticles
C Liu (2007)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1039/B811923F
Advanced nanogel engineering for drug delivery
K. Raemdonck (2009)
10.1016/J.JCONREL.2005.11.014
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
M. Amidi (2006)
10.1211/0022357022539
Is nose‐to‐brain transport of drugs in man a reality?
L. Illum (2004)
10.2500/ajr.2007.21.3007
Effectiveness of Topical Antibiotics on Staphylococcus Aureus Biofilm in Vitro
M. Desrosiers (2007)
10.1016/J.PROGPOLYMSCI.2008.01.002
The development of microgels/nanogels for drug delivery applications
J. Oh (2008)
10.1080/10717540490280750
Development and Characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery
S. Jain (2004)
10.1016/j.ijpharm.2007.11.027
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Kapil Khatri (2008)
10.1517/17425247.5.10.1159
From nose to brain: understanding transport capacity and transport rate of drugs.
H. Wu (2008)
10.3126/KUSET.V5I1.2848
In Vitro Drug Release Studies from a Novel Lyophilised Nasal Dosage Form
P. Thapa (2010)
10.1023/A:1011929016601
Chitosan and its use as a pharmaceutical excipient.
L. Illum (1998)
10.1016/j.ijpharm.2009.06.019
Nanoparticles for direct nose-to-brain delivery of drugs.
Alpesh Mistry (2009)
Nasal systemic drug delivery
Y. Chien (1989)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0378-5173(99)00125-8
Chitosan microspheres prepared by spray drying.
P. He (1999)
10.1002/anie.200900441
Nanogels as pharmaceutical carriers: finite networks of infinite capabilities.
A. Kabanov (2009)
10.1016/J.ADDR.2005.07.002
Thiomers: a new generation of mucoadhesive polymers.
A. Bernkop-Schnürch (2005)
10.1080/10611860701637966
Rational design of nasal vaccines.
B. Slütter (2008)
10.1016/J.IJPHARM.2005.09.013
Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
E. Gavini (2006)
Chitosan/pectin polyelectrolyte complexes for nasal delivery of antipsychotic drugs
B. Luppi (2010)
10.2500/ajr.2008.22.3189
Topical Antimicrobials in the Management of Chronic Rhinosinusitis: A Systematic Review
M. Lim (2008)
10.1016/J.EJPB.2007.06.020
A novel thermoresponsive hydrogel based on chitosan.
Yannic B. Schuetz (2008)
10.1208/aapsj060320
Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia
D. Burgess (2008)
10.1016/S0264-410X(02)00662-X
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
M. Iqbal (2003)
10.1517/17425240903114142
Chitosan and its salts for mucosal and transmucosal delivery
M. C. Bonferoni (2009)
10.3390/ma2020577
Micro- and Nanoscale Hydrogel Systems for Drug Delivery and Tissue Engineering
C. Schwall (2009)
10.1023/B:PHAM.0000012150.60180.e3
Effect of Chitosan on Epithelial Cell Tight Junctions
J. Smith (2004)
10.1016/S0169-409X(97)00067-7
Nasal delivery systems and their effect on deposition and absorption.
Vidgren (1998)
Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration
R. Fernández-Urrusuno (1999)
10.1211/jpp/61.05.0017
Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
S. Khan (2009)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1007/S11802-007-0237-9
Preparations,Characterizations and Applications of Chitosan-based Nanoparticles
Liu Chen-guang (2007)
10.1002/JPS.21043
Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.
G. Di Colo (2008)
10.1002/jps.21674
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
S. R. K. Vaka (2009)
10.1080/10408690390826455
Chitin — The Undisputed Biomolecule of Great Potential
R. Tharanathan (2003)
10.1016/S0169-409X(98)00073-8
Intranasal insulin delivery and therapy.
Hinchcliffe (1999)
10.1016/J.ADDR.2006.09.004
Hydrogels in controlled release formulations: network design and mathematical modeling.
Chien-Chi Lin (2006)
10.3109/10731199009117286
Chitosan--as a biomaterial.
T. Chandy (1990)
10.1016/J.EJPS.2007.02.002
Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
F. Mcinnes (2007)
Therapeutic targets in rhinosinusitis: infection or inflammation?
V. Lund (2008)
10.1016/J.IJPHARM.2004.05.007
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Shaoyun Yu (2004)
10.1016/J.IJPHARM.2005.07.025
In vivo evaluation of nicotine lyophilised nasal insert in sheep.
F. Mcinnes (2005)
Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
C. Sankar (2001)
Nasal delivery of insulin using bioadhesive CH gels
J Varshosaz (2006)
10.1211/jpp/61.02.0003
Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
B. Luppi (2009)
10.1080/03639040802360510
Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir.
I. Alsarra (2009)
10.1016/J.IJPHARM.2007.03.025
Intranasal delivery: physicochemical and therapeutic aspects.
H. Costantino (2007)
10.2165/00002018-200326120-00003
Safety and Tolerability Profiles of Intranasal Antihistamines and Intranasal Corticosteroids in the Treatment of Allergic Rhinitis
R. Salib (2003)
10.1002/JPS.20318
Nasal drug administration: potential for targeted central nervous system delivery.
Candace L. Graff (2005)
10.1016/J.ADDR.2005.07.001
The basics and underlying mechanisms of mucoadhesion.
J. Smart (2005)
10.1021/JA065867X
A controlled-release strategy for the generation of cross-linked hydrogel microstructures.
Giovanni Talei Franzesi (2006)
10.1016/J.PROGPOLYMSCI.2006.06.001
Chitin and chitosan: Properties and applications
M. Rinaudo (2006)
10.1208/pt0804081
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination
Robert J. Garmise (2008)
Pharmacokinetic attributes of intranasal delivery: case studies and new opportunities
HR Costantino (2005)



This paper is referenced by
10.1016/j.ejps.2019.02.015
Cromolyn‐crosslinked chitosan nanoparticles for the treatment of allergic rhinitis
A. Abruzzo (2019)
10.30476/TIPS.2019.81604.1002
Hydrogels as Drug Delivery Systems; Pros and Cons
Parisa Ghasemiyeh (2019)
10.1016/j.ijbiomac.2012.09.001
Physiochemical and optical study of chitosan-terephthaldehyde derivative for biomedical applications.
S. Kumar (2012)
10.1007/978-3-662-45013-0_20
Hydrogel vehicles for hydrophilic compounds
T. Cerchiara (2015)
Fwd: [PJ]:Acknowledgment of Online Submission
(2019)
10.1007/8415_2010_55
Chitosan-Derivative Based Hydrogels as Drug Delivery Platforms: Applications in Drug Delivery and Tissue Engineering
M. Roldo (2011)
10.1021/cr200157d
Hydrogels for protein delivery.
T. Vermonden (2012)
10.1016/j.msec.2016.03.091
Nasal inserts containing ondansetron hydrochloride based on Chitosan-gellan gum polyelectrolyte complex: In vitro-in vivo studies.
Ashish G Sonje (2016)
10.1007/s00396-015-3538-3
Catharanthus roseus leaf extract-synthesized chitosan nanoparticles for controlled in vitro release of chloramphenicol and ketoconazole
Dipali Nagaonkar (2015)
10.6092/UNIBO/AMSDOTTORATO/5614
Chitosan based hydrogels for transmucosal drug delivery
A. Abruzzo (2013)
10.22159/AJPCR.2017.V10I5.16936
CHARACTERIZATION OF NANOPARTICLES PRODUCED BY CHLOROFORM FRACTION OF KAEMPFERIA ROTUNDA RHIZOME LOADED WITH ALGINIC ACID AND CHITOSAN AND ITS BIOLOGICAL ACTIVITY TEST
S. Atun (2017)
10.1016/j.ijpharm.2019.05.050
An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage.
Tingwang Guo (2019)
10.1007/s12010-017-2570-9
Natural or Natural-Synthetic Hybrid Polymer-Based Fluorescent Polymeric Materials for Bio-imaging-Related Applications
X. Ma (2017)
10.5530/pj.2017.2.24
Synthesis of Nanoparticles Produced by Ethanol Extract of Boesenbergia rotunda Rhizome Loaded with Chitosan and Alginic Acid and its Biological Activity test
S. Atun (2017)
10.1002/lary.23583
Sprayable chitosan/starch‐based sealant reduces adhesion formation in a sheep model for Chronic sinusitis
J. Medina (2013)
10.1007/s40005-019-00436-0
In situ gel of lamotrigine for augmented brain delivery: development characterization and pharmacokinetic evaluation
Poonam Parashar (2019)
10.1002/jps.23836
Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.
T. Musumeci (2014)
10.1016/j.ejps.2013.07.006
The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA.
K. Chen (2013)
10.3109/1061186X.2013.805335
Novel engineered systems for oral, mucosal and transdermal drug delivery
Hairui Li (2013)
10.1016/j.mehy.2013.09.027
Should chitosan and tranexamic acid be combined for improved hemostasis after sinus surgery?
J. Bartley (2013)
10.3109/1061186X.2011.654121
Chitosan nanoparticles: a survey of preparation methods
A. Grenha (2012)
10.2500/ajra.2017.31.4469
Influence of Chitosan-Based Dressing on Prevention of Synechia and Wound Healing after Endoscopic Sinus Surgery: A Meta-Analysis
J. Liu (2017)
10.1016/j.ejpb.2012.10.010
Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
E. Gavini (2013)
10.4314/TJPR.V13I3.22
Nasal Inserts for Drug Delivery: An Overview
E. Algın-Yapar (2014)
10.1081/e-ebpp-120051261
Controlled Release: Porous Polymer Application
Narendra Pal Singh Chauhan (2015)
10.1002/jps.24059
pH-Sensitive cationic copolymers of different macromolecular architecture as potential dexamethasone sodium phosphate delivery systems.
D. Georgieva (2014)
10.1177/0194599812443647
A Chitosan-Based Sinus Sealant for Reduction of Adhesion Formation in Rabbit and Sheep Models
J. Medina (2012)
Preparation and evaluation of a thermosensitive hydrogel for the nasal delivery of insulin
H. Nazar (2012)
10.1016/j.biomaterials.2012.06.104
Biomedical applications of amino acid-modified chitosans: a review.
L. Casettari (2012)
10.1007/978-3-319-00978-0_13
Chitosan-Based Adjuvants
G. Gafvelin (2014)
10.1016/j.jconrel.2012.01.024
Nasal drug delivery - recent developments and future prospects.
L. Illum (2012)
10.1007/s13346-012-0086-y
Microparticles based on chitosan/pectin polyelectrolyte complexes for nasal delivery of tacrine hydrochloride
B. Saladini (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar